Live Breaking News & Updates on American Epilepsy Society Annual Meeting

Stay updated with breaking news from American epilepsy society annual meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

Reported fourth quarter 2023 revenue from continuing operations1 of $58.1M with more than 68% year-over-year growth of exome and genome test revenue Expanded fourth quarter 2023 adjusted gross. ....

United States , New York , Katherine Stueland , American Epilepsy Society Annual Meeting , Globenewswire Inc , Google Health , Exchange Commission , Company Class , York Center , American College Of Medical Genetics , University Of Washington , Genedx Holdings Corp , Chief Executive Officer , Full Year , Legacy Sema , Legacy Genedx , Epilepsy Society Annual Meeting , Medical Genetics , Rare Diseases , Chief Growth Officer , Chief Product , Conference Call , Annual Report , Relations Contact , Select Financial Information ,

GeneDx Reports Fourth Quarter and Full Year 2023 Financial

GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023.. ....

United States , New York , Katherine Stueland , American College Of Medical Genetics , Company Class , Genedx Holdings Corp , American Epilepsy Society Annual Meeting , Exchange Commission , Google Health , York Center , University Of Washington , Chief Executive Officer , Full Year , Legacy Sema , Legacy Genedx , American College , Medical Genetics , New York Center , Rare Diseases , Melanie Duquette , Chief Growth Officer , Eric Olivares , Chief Product , Conference Call , Annual Report , Relations Contact ,

Earnings: GES and Spiro Parent Company Viad Positive on 2024 After Double-Digit Revenue Growth in Q4 2023

Viad Corp., parent of Global Experience Specialists (GES) ....

United States , Jeff Quade , Steve Moster , Viad Corp , Orange County Convention Center , American Epilepsy Society Annual Meeting , Global Experience Specialists , American Epilepsy Society , Annual Meeting , North America , Jason Stead ,

UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting

Study presents new persistence analysis of FINTEPLA, evaluating the efficacy and tolerability of FINTEPLA over a span of 12 months1 Real-world data looks into the need for resources to support caregivers – both parents and siblings – of people living with developmental and epileptic encephalopathies such as Dravet and Lennox-Gastaut syndromes in the transition from […] ....

United States , Bruxelles Capitale , Becky Malone , Lauried Bailey , Tom Stanton , Brad Chapman , Antje Witte , Rare Epilepsy Parents , A Survey Of Rare Epilepsy Parents , Program See Boxed Warning , Guideline Development , Group Of Companies , Epilepsy Foundation , Corporate Communications , Child Neurology Foundation , Bull World Health Organ , Ucb Inc , American Epilepsy Society Annual Meeting , Danny Did Foundation , American Epilepsy Society , Annual Meeting , Rare Syndromes , Month Persistence Analysis , Dravet Syndrome , Komodo Healthcare , Adult Siblings ,

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

RNS System featured in over 50 Scientific Presentations and PostersMOUNTAIN VIEW, Calif., Dec. 01, 2023 NeuroPace, Inc. , a commercial-stage medical device company focused on transforming the. ....

United States , Orange County Convention Center , Martha Morrell , Jeremy Feffer , Neuropace Inc , American Epilepsy Society Annual Meeting , Exchange Commission , Chief Medical , Event Details , Networking Reception , Advanced Neuromodulation Practice Post Fellowship , Responsive Neuromodulation , Informing Future Epilepsy , Generalized Epilepsies , Product Theater , Exhibit Hall , Orange County Convention , Future Artificial Intelligence Applications , Mountain View , Financial Condition , Quarterly Report ,